Logo image
Back
Measles immunization in HIV-infected children
Journal article   Peer reviewed

Measles immunization in HIV-infected children

N A Halsey, J S Abramson, P J Chesney, M C Fisher, M A Gerber, S M Marcy, D L Murray, G D Overturf, C G Prober, L B Weiner, …
Pediatrics (Evanston), v 103(5), pp 1057-1060
01 May 1999
DOI: https://doi.org/10.1542/peds.103.5.1057
PMID: 10224192
Featured in Collection :   UN Sustainable Development Goals @ Drexel

Abstract

Life Sciences & Biomedicine Pediatrics Science & Technology
Children infected with human immunodeficiency virus (HIV) have had high rates of mortality attributable to measles, but until recently, measles vaccine was assumed to be safe for these children. A single fatal case of pneumonia attributable to vaccine type-measles virus has been documented in a young adult with acquired immunodeficiency syndrome. Because a protective immune response often does not develop in severely immunocompromised HIV-infected patients after immunization and some risk of severe complications exists, HIV-infected children, adolescents, and young adults who are severely immunocompromised (based on age-specific CD4 lymphocyte enumeration) attributable to HIV infection should not receive measles vaccine, All other HIV-infected children, adolescents, and young adults who are not severely immunocompromised should receive measles-mumps-rubella vaccine.

Metrics

4 Record Views
27 citations in Web of Science
56 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Pediatrics
Logo image